Tonix Pharmaceuticals Holding Corp [NASDAQ: TNXP] gained 0.88% or 0.31 points to close at $35.48 with a heavy trading volume of 277363 shares.
It opened the trading session at $35.34, the shares rose to $35.69 and dropped to $34.725, the range by which the price of stock traded the whole day. The daily chart for TNXP points out that the company has recorded -1.47% loss over the past six months.
If we look at the average trading volume of 936.47K shares, TNXP reached to a volume of 277363 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Tonix Pharmaceuticals Holding Corp [TNXP]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TNXP shares is $61.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TNXP stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Noble Capital Markets have made an estimate for Tonix Pharmaceuticals Holding Corp shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on April 18, 2022. The new note on the price target was released on April 18, 2019, representing the official price target for Tonix Pharmaceuticals Holding Corp stock. Previously, the target price had yet another raise to $6, while ROTH Capital analysts kept a Buy rating on TNXP stock.
The Price to Book ratio for the last quarter was 1.35, with the Price to Cash per share for the same quarter was set at 17.90.
Trading performance analysis for TNXP stock
Tonix Pharmaceuticals Holding Corp [TNXP] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.17. With this latest performance, TNXP shares dropped by -12.29% in over the last four-week period, additionally sinking by -1.47% over the last 6 months – not to mention a rise of 7.58% in the past year of trading.
Tonix Pharmaceuticals Holding Corp [TNXP]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Tonix Pharmaceuticals Holding Corp [TNXP] shares currently have an operating margin of -721.51% and a Gross Margin at 2.98%. Tonix Pharmaceuticals Holding Corp’s Net Margin is presently recorded at -1313.87%.
Return on Equity for this stock declined to -80.39%, with Return on Assets sitting at -80.39%.
Tonix Pharmaceuticals Holding Corp [TNXP]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TNXP. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Tonix Pharmaceuticals Holding Corp go to 88.07%.
An analysis of Institutional ownership at Tonix Pharmaceuticals Holding Corp [TNXP]
There are presently around $7.03%, or 7.04% of TNXP stock, in the hands of institutional investors. The top three institutional holders of TNXP stocks are: PRUDENTIAL FINANCIAL INC with ownership of 97707.0 shares, which is approximately 0.0239%. ALYESKA INVESTMENT GROUP, L.P., holding 62500.0 shares of the stock with an approximate value of $$43588.0 in TNXP stocks shares; and ALYESKA INVESTMENT GROUP, L.P., currently with $$39000.0 in TNXP stock with ownership which is approximately 0.0141%.
